UGT1A1 and Hyperbilirubinemia: Overall analyses suggested an increased risk of hyperbilirubinemia in HIV-positive patients with a UGT1A1*1/*28 genotype as compared with those with a wild-type allele (OR = 3.50, 95%CI = 1.35–9.08; P=0.01) (Figure 2B).